MAP3K7 and cardiac hypertrophy: As expected, the prooxidative and proferroptosis role of glycosylated CD147 in pathological cardiac hypertrophy was significantly blunted in mice treated with the TAK1 inhibitor (Figures 7(c) and 7(e)).